Aristo Bio-Tech & Lifescience Ltd Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Cr

Standalone Annual Results

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Mar 2025 is 29.75% vs 12.53% in Mar 2024

Standalone Net Profit

YoY Growth in year ended Mar 2025 is 4.10% vs 9.55% in Mar 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 9.19% vs -2.53% in Mar 2024

Interest

YoY Growth in year ended Mar 2025 is -1.78% vs -38.55% in Mar 2024

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Aristo Bio-Tech With

Select Peers

Figures in Cr

Standalone Annual Results

Change(INR)

Change(%)

Net Sales

318.09

90.51

227.58

251.44%

Other Operating Income

0.00

Total Operating income

318.09

90.51

227.58

251.44%

Raw Material Cost

295.60

57.60

238.00

413.19%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

-0.07

-2.05

1.98

96.59%

Employee Cost

4.10

9.64

-5.54

-57.47%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

9.19

16.26

-7.07

-43.48%

Total Expenditure (Excl Depreciation)

308.82

81.45

227.37

279.15%

Operating Profit (PBDIT) excl Other Income

9.27

9.06

0.21

2.32%

Other Income

0.45

0.09

0.36

400.00%

Operating Profit (PBDIT)

9.72

9.15

0.57

6.23%

Interest

1.66

2.00

-0.34

-17.00%

Exceptional Items

0.00

Gross Profit (PBDT)

8.06

7.15

0.91

12.73%

Depreciation

2.60

1.74

0.86

49.43%

Profit Before Tax

5.47

5.40

0.07

1.30%

Tax

1.40

1.50

-0.10

-6.67%

Provisions and contingencies

0.00

Profit After Tax

4.06

3.90

0.16

4.10%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

4.06

3.90

0.16

4.10%

Equity Capital

6.81

5.21

1.60

30.71%

Face Value

10.00

0.00

Reserves

30.52

12.54

17.98

143.38%

Earnings per share (EPS)

5.96

7.49

-1.53

-20.43%

Diluted Earnings per share

5.97

7.48

-1.51

-20.19%

Operating Profit Margin (Excl OI)

2.91%

10.01%

0.00

-7.10%

Gross Profit Margin

2.53%

7.90%

0.00

-5.37%

PAT Margin

1.28%

4.31%

0.00

-3.03%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Annual - Net Sales

Net Sales 318.09 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 29.75% vs 12.53% in Mar 2024

Annual - Standalone Net Profit

Standalone Net Profit 4.06 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 4.10% vs 9.55% in Mar 2024

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 9.27 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 9.19% vs -2.53% in Mar 2024

Annual - Interest

Interest 1.66 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is -1.78% vs -38.55% in Mar 2024

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 2.91%

in Mar 2025

Figures in %

YoY Growth in year ended Mar 2025 has fallen from Mar 2024